Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

NCT05831111

Conditions
DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +12 more
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • Noble Clinical Research Tucson, Arizona, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • Tekton Research Longmont, Colorado, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome

NCT03837483

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Children's Healthcare of Atlanta, Inc Atlanta, Georgia, United States
  • Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR-TIGET) Milan, Italy
View Trial Details
Active, Not Recruiting

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

NCT04606433

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View Trial Details
Active, Not Recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

NCT05104775

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +11 more
Locations
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Active, Not Recruiting

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

NCT04378855

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Asl Di Asti, Ospedali Riuniti - Presidio Ospedaliero Cardinal G. Massaia - Sc Oncologia Asti, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
  • Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia Bari, Italy
View all 25 locations
View Trial Details

Related conditions